Selected research
Industry Growth & Trends
Global Memantine Hydrochloride Tablets Industry Growth and Trends Forecast to 2032
Market perspective
The global Memantine Hydrochloride Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Memantine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Memantine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Memantine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Memantine Hydrochloride Tablets include Teva Pharmaceuticals USA, Sun Pharma, United Laboratories, Upsher-Smith, Taj Pharma India Limited, Sharon Bio-medicine Limited, Psycogen Captab, Kabir Lifesciences and Consern Pharma Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Memantine Hydrochloride Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Memantine Hydrochloride Tablets market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Memantine Hydrochloride Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Memantine Hydrochloride Tablets.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Memantine Hydrochloride Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Memantine Hydrochloride Tablets Market by Company
Teva Pharmaceuticals USA
Sun Pharma
United Laboratories
Upsher-Smith
Taj Pharma India Limited
Sharon Bio-medicine Limited
Psycogen Captab
Kabir Lifesciences
Consern Pharma Limited
Aripolis Biotech Pvt. Ltd.
Ajanta Pharma Ltd.
Actiza Pharmaceutical Pvt. Ltd.
Memantine Hydrochloride Tablets Segment by Type
Immediate-Release Tablets
Extended-Release Tablets
Memantine Hydrochloride Tablets Segment by Application
Retail Pharmacy
Hospital Pharmacy
Online Pharmacy
Memantine Hydrochloride Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Memantine Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Memantine Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Memantine Hydrochloride Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Memantine Hydrochloride Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Memantine Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Immediate-Release Tablets
- Extended-Release Tablets
Applications
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
Companies covered
- Teva Pharmaceuticals USA
- Sun Pharma
- United Laboratories
- Upsher-Smith
- Taj Pharma India Limited
- Sharon Bio-medicine Limited
- Psycogen Captab
- Kabir Lifesciences
- Consern Pharma Limited
- Aripolis Biotech Pvt. Ltd.
- Ajanta Pharma Ltd.
- Actiza Pharmaceutical Pvt. Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Memantine Hydrochloride Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Memantine Hydrochloride Tablets Sales Estimates and Forecasts (2021-2032)
- 1.3 Memantine Hydrochloride Tablets Market by Type
- 1.3.1 Immediate-Release Tablets
- 1.3.2 Extended-Release Tablets
- 1.4 Global Memantine Hydrochloride Tablets Market Size by Type
- 1.4.1 Global Memantine Hydrochloride Tablets Market Size Overview by Type (2021-2032)
- 1.4.2 Global Memantine Hydrochloride Tablets Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Memantine Hydrochloride Tablets Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Memantine Hydrochloride Tablets Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Memantine Hydrochloride Tablets Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Memantine Hydrochloride Tablets Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Memantine Hydrochloride Tablets Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Memantine Hydrochloride Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Memantine Hydrochloride Tablets Industry Trends
- 2.2 Memantine Hydrochloride Tablets Industry Drivers
- 2.3 Memantine Hydrochloride Tablets Industry Opportunities and Challenges
- 2.4 Memantine Hydrochloride Tablets Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Memantine Hydrochloride Tablets Revenue (2021-2026)
- 3.2 Global Top Players by Memantine Hydrochloride Tablets Sales (2021-2026)
- 3.3 Global Top Players by Memantine Hydrochloride Tablets Price (2021-2026)
- 3.4 Global Memantine Hydrochloride Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Memantine Hydrochloride Tablets Major Company Production Sites & Headquarters
- 3.6 Global Memantine Hydrochloride Tablets Company, Product Type & Application
- 3.7 Global Memantine Hydrochloride Tablets Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Memantine Hydrochloride Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Memantine Hydrochloride Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Memantine Hydrochloride Tablets Tier 1, Tier 2, and Tier 3
4 Memantine Hydrochloride Tablets Regional Status and Outlook
- 4.1 Global Memantine Hydrochloride Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Memantine Hydrochloride Tablets Historic Market Size by Region
- 4.2.1 Global Memantine Hydrochloride Tablets Sales in Volume by Region (2021-2026)
- 4.2.2 Global Memantine Hydrochloride Tablets Sales in Value by Region (2021-2026)
- 4.2.3 Global Memantine Hydrochloride Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Memantine Hydrochloride Tablets Forecasted Market Size by Region
- 4.3.1 Global Memantine Hydrochloride Tablets Sales in Volume by Region (2027-2032)
- 4.3.2 Global Memantine Hydrochloride Tablets Sales in Value by Region (2027-2032)
- 4.3.3 Global Memantine Hydrochloride Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Memantine Hydrochloride Tablets by Application
- 5.1 Memantine Hydrochloride Tablets Market by Application
- 5.1.1 Retail Pharmacy
- 5.1.2 Hospital Pharmacy
- 5.1.3 Online Pharmacy
- 5.2 Global Memantine Hydrochloride Tablets Market Size by Application
- 5.2.1 Global Memantine Hydrochloride Tablets Market Size Overview by Application (2021-2032)
- 5.2.2 Global Memantine Hydrochloride Tablets Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Memantine Hydrochloride Tablets Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Memantine Hydrochloride Tablets Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Memantine Hydrochloride Tablets Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Memantine Hydrochloride Tablets Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Memantine Hydrochloride Tablets Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Memantine Hydrochloride Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva Pharmaceuticals USA
- 6.1.1 Teva Pharmaceuticals USA Company Information
- 6.1.2 Teva Pharmaceuticals USA Business Overview
- 6.1.3 Teva Pharmaceuticals USA Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Pharmaceuticals USA Memantine Hydrochloride Tablets Product Portfolio
- 6.1.5 Teva Pharmaceuticals USA Recent Developments
- 6.2 Sun Pharma
- 6.2.1 Sun Pharma Company Information
- 6.2.2 Sun Pharma Business Overview
- 6.2.3 Sun Pharma Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sun Pharma Memantine Hydrochloride Tablets Product Portfolio
- 6.2.5 Sun Pharma Recent Developments
- 6.3 United Laboratories
- 6.3.1 United Laboratories Company Information
- 6.3.2 United Laboratories Business Overview
- 6.3.3 United Laboratories Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 United Laboratories Memantine Hydrochloride Tablets Product Portfolio
- 6.3.5 United Laboratories Recent Developments
- 6.4 Upsher-Smith
- 6.4.1 Upsher-Smith Company Information
- 6.4.2 Upsher-Smith Business Overview
- 6.4.3 Upsher-Smith Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Upsher-Smith Memantine Hydrochloride Tablets Product Portfolio
- 6.4.5 Upsher-Smith Recent Developments
- 6.5 Taj Pharma India Limited
- 6.5.1 Taj Pharma India Limited Company Information
- 6.5.2 Taj Pharma India Limited Business Overview
- 6.5.3 Taj Pharma India Limited Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Taj Pharma India Limited Memantine Hydrochloride Tablets Product Portfolio
- 6.5.5 Taj Pharma India Limited Recent Developments
- 6.6 Sharon Bio-medicine Limited
- 6.6.1 Sharon Bio-medicine Limited Company Information
- 6.6.2 Sharon Bio-medicine Limited Business Overview
- 6.6.3 Sharon Bio-medicine Limited Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Sharon Bio-medicine Limited Memantine Hydrochloride Tablets Product Portfolio
- 6.6.5 Sharon Bio-medicine Limited Recent Developments
- 6.7 Psycogen Captab
- 6.7.1 Psycogen Captab Company Information
- 6.7.2 Psycogen Captab Business Overview
- 6.7.3 Psycogen Captab Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Psycogen Captab Memantine Hydrochloride Tablets Product Portfolio
- 6.7.5 Psycogen Captab Recent Developments
- 6.8 Kabir Lifesciences
- 6.8.1 Kabir Lifesciences Company Information
- 6.8.2 Kabir Lifesciences Business Overview
- 6.8.3 Kabir Lifesciences Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Kabir Lifesciences Memantine Hydrochloride Tablets Product Portfolio
- 6.8.5 Kabir Lifesciences Recent Developments
- 6.9 Consern Pharma Limited
- 6.9.1 Consern Pharma Limited Company Information
- 6.9.2 Consern Pharma Limited Business Overview
- 6.9.3 Consern Pharma Limited Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Consern Pharma Limited Memantine Hydrochloride Tablets Product Portfolio
- 6.9.5 Consern Pharma Limited Recent Developments
- 6.10 Aripolis Biotech Pvt. Ltd.
- 6.10.1 Aripolis Biotech Pvt. Ltd. Company Information
- 6.10.2 Aripolis Biotech Pvt. Ltd. Business Overview
- 6.10.3 Aripolis Biotech Pvt. Ltd. Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Aripolis Biotech Pvt. Ltd. Memantine Hydrochloride Tablets Product Portfolio
- 6.10.5 Aripolis Biotech Pvt. Ltd. Recent Developments
- 6.11 Ajanta Pharma Ltd.
- 6.11.1 Ajanta Pharma Ltd. Company Information
- 6.11.2 Ajanta Pharma Ltd. Business Overview
- 6.11.3 Ajanta Pharma Ltd. Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Ajanta Pharma Ltd. Memantine Hydrochloride Tablets Product Portfolio
- 6.11.5 Ajanta Pharma Ltd. Recent Developments
- 6.12 Actiza Pharmaceutical Pvt. Ltd.
- 6.12.1 Actiza Pharmaceutical Pvt. Ltd. Company Information
- 6.12.2 Actiza Pharmaceutical Pvt. Ltd. Business Overview
- 6.12.3 Actiza Pharmaceutical Pvt. Ltd. Memantine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Actiza Pharmaceutical Pvt. Ltd. Memantine Hydrochloride Tablets Product Portfolio
- 6.12.5 Actiza Pharmaceutical Pvt. Ltd. Recent Developments
7 North America by Country
- 7.1 North America Memantine Hydrochloride Tablets Sales by Country
- 7.1.1 North America Memantine Hydrochloride Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Memantine Hydrochloride Tablets Sales by Country (2021-2026)
- 7.1.3 North America Memantine Hydrochloride Tablets Sales Forecast by Country (2027-2032)
- 7.2 North America Memantine Hydrochloride Tablets Market Size by Country
- 7.2.1 North America Memantine Hydrochloride Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Memantine Hydrochloride Tablets Market Size by Country (2021-2026)
- 7.2.3 North America Memantine Hydrochloride Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Memantine Hydrochloride Tablets Sales by Country
- 8.1.1 Europe Memantine Hydrochloride Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Memantine Hydrochloride Tablets Sales by Country (2021-2026)
- 8.1.3 Europe Memantine Hydrochloride Tablets Sales Forecast by Country (2027-2032)
- 8.2 Europe Memantine Hydrochloride Tablets Market Size by Country
- 8.2.1 Europe Memantine Hydrochloride Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Memantine Hydrochloride Tablets Market Size by Country (2021-2026)
- 8.2.3 Europe Memantine Hydrochloride Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Memantine Hydrochloride Tablets Sales by Country
- 9.1.1 Asia-Pacific Memantine Hydrochloride Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Memantine Hydrochloride Tablets Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Memantine Hydrochloride Tablets Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Memantine Hydrochloride Tablets Market Size by Country
- 9.2.1 Asia-Pacific Memantine Hydrochloride Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Memantine Hydrochloride Tablets Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Memantine Hydrochloride Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Memantine Hydrochloride Tablets Sales by Country
- 10.1.1 South America Memantine Hydrochloride Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Memantine Hydrochloride Tablets Sales by Country (2021-2026)
- 10.1.3 South America Memantine Hydrochloride Tablets Sales Forecast by Country (2027-2032)
- 10.2 South America Memantine Hydrochloride Tablets Market Size by Country
- 10.2.1 South America Memantine Hydrochloride Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Memantine Hydrochloride Tablets Market Size by Country (2021-2026)
- 10.2.3 South America Memantine Hydrochloride Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Memantine Hydrochloride Tablets Sales by Country
- 11.1.1 Middle East and Africa Memantine Hydrochloride Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Memantine Hydrochloride Tablets Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Memantine Hydrochloride Tablets Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Memantine Hydrochloride Tablets Market Size by Country
- 11.2.1 Middle East and Africa Memantine Hydrochloride Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Memantine Hydrochloride Tablets Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Memantine Hydrochloride Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Memantine Hydrochloride Tablets Value Chain Analysis
- 12.1.1 Memantine Hydrochloride Tablets Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Memantine Hydrochloride Tablets Production Mode & Process
- 12.2 Memantine Hydrochloride Tablets Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Memantine Hydrochloride Tablets Distributors
- 12.2.3 Memantine Hydrochloride Tablets Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst